Home / Brands / Lowlite Investments, Inc.
Lowlite Investments, Inc. Recalls
105 recalls on record · July 17, 2013 to July 17, 2013 · Drugs
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Bi mix, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Betamethasone Phosphate/Acetate 6 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Betamethasone Sodium Phosphate 12 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Beta Alanine 100 mg/ml / l-carnosine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Atropine Sulfate 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Atipamezole 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Aminophylline 2.5% Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Aminocaproic Acid 0.5mg/ml Injection,compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Aminocaproic Acid 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Amikacin Sulfate 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Altrenogest 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Alprostadil 2000 mcg/ml, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Adenosine-Mono-Phosphate Injection, 200 mg/ml, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Acepromazine 25 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Acetyl-D-Glucosamine w/Chondroitin 200 mg/ml, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes